Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
RPG Life Sciences Limited
RPGLIFERPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, and anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology, cardiovascular, pediatrics, neurology, anti-dengue, and dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust. Address: RPG House, Mumbai, India, 400030
Analytics
Zielpreis von Wall Street
40 359.09 INRKGV
50.5011Dividendenrendite
0.75 %Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen RPGLIFE
Dividenden-Analyse RPGLIFE
Dividendenwachstum über 5 Jahre
400 %Kontinuierliches Wachstum
4 JahreAusschüttungsquote 5-Jahres-Durchschnitt
30 %Verlauf der Dividende RPGLIFE
Bewertung der Aktie RPGLIFE
Finanzen RPGLIFE
Ergebnisse | 2019 | Dynamik |